88 related articles for article (PubMed ID: 7277684)
1. [Neuroleptanesthesia for a patient with porphyria (author's transl)].
Kuba Y; Saito N; Oda M; Aono M
Masui; 1981 Feb; 30(2):193-9. PubMed ID: 7277684
[No Abstract] [Full Text] [Related]
2. [Modified neuroleptanesthesia for pheochromocytoma (author's transl)].
Kondo S; Nosaka S; Ishibashi T; Amakata Y
Masui; 1981 Feb; 30(2):183-8. PubMed ID: 7277682
[No Abstract] [Full Text] [Related]
3. [Study of cardiovascular effect of neuroleptanesthesia (Part II)--comparative study of cardiovascular effects of original NLA and modified NLA (author's transl)].
Sone T
Masui; 1980 Apr; 29(4):317-24. PubMed ID: 7382099
[No Abstract] [Full Text] [Related]
4. [Deep hypothermia by surface cooling with neuroleptanesthesia (author's transl)].
Baba K
Nihon Kyobu Geka Gakkai Zasshi; 1977 Oct; 25(10):1241-54. PubMed ID: 608997
[No Abstract] [Full Text] [Related]
5. [Evaluation of trimetaphan (Arfonad) during laryngomicrosurgery under modified neuroleptanalgesia (author's transl)].
Kuroda N; Shima T; Matsukawa S; Nishioka K
Masui; 1980 Aug; 29(8):778-83. PubMed ID: 7009908
[No Abstract] [Full Text] [Related]
6. [Cardiovascular effects of dopamine during neuroleptanaesthesia (author's transl)].
Piepenbrock S; Reichelt W; Schleussner E; Schaps D; Matz HJ
Anasth Intensivther Notfallmed; 1980 Dec; 15(6):460-9. PubMed ID: 6971586
[No Abstract] [Full Text] [Related]
7. [Anesthesia in pediatric radiology-modified neuroleptanalgesia (author's transl)].
Hashimoto S; Ogino H; Ohara Y; Murata M; Matsuo M; Nishiyama S
Rinsho Hoshasen; 1978 Oct; 23(10):1043-6. PubMed ID: 702881
[No Abstract] [Full Text] [Related]
8. [The effects of Ca++ antagonistic drug, verapamil, on heart rate, arterial blood pressure, ECG, and blood catecholamine concentration during neuroleptanesthesia (author's transl)].
Nishimoto T; Shibata O; Haseba S; Goto Y; Hagiwara M
Masui; 1981 Dec; 30(12):1310-6. PubMed ID: 7346646
[No Abstract] [Full Text] [Related]
9. [A comparison between butorphanol and pentazocine as analgesics in modified neuroleptanesthesia].
Ito K; Momose T; Enomoto N; Yogosawa T; Yamada M; Kuge T
Masui; 1982 Dec; 31(12):1351-8. PubMed ID: 7166790
[No Abstract] [Full Text] [Related]
10. [Suburoporphyrins in symptomatic hepatic porphyria and in experimental porphyria (author's transl)].
Kaláb M; Jirsa M; Kordac V; Soldátová H
Cas Lek Cesk; 1981 Oct; 120(41):1251-4. PubMed ID: 7344798
[No Abstract] [Full Text] [Related]
11. [Application of butorphanol for modified neuroleptanesthesia--a controlled comparative study of butorphanol and pentazocine].
Hanaoka K; Kugimiya T; Yamamura H
Masui; 1982 Jul; 31(7):727-35. PubMed ID: 7131748
[No Abstract] [Full Text] [Related]
12. [Acute myocardial infarction during neuroleptanesthesia -a case report- (author's transl)].
Horikawa H; Higuchi T; Tada T; Ichiyanagi K
Masui; 1981 Sep; 30(9):973-7. PubMed ID: 7328743
[No Abstract] [Full Text] [Related]
13. [Clinical evaluation of modified cyclazocine neuroleptanesthesia--a report by a Group on the Study of Modified Cyclazocine NLA].
Yamamura H; Kugimiya T; Hanaoka K; Inada Y; Tachibana N
Masui; 1983 Sep; 32(9):1095-103. PubMed ID: 6663698
[No Abstract] [Full Text] [Related]
14. [Study of cardiovascular effect of neuroleptanesthesia (Part I)--cardiovascular effect of pentazocine (author's transl)].
Sone T
Masui; 1980 Mar; 29(3):225-31. PubMed ID: 7373840
[No Abstract] [Full Text] [Related]
15. [Application of cyclazocine in modified neuroleptanesthesia].
Niiya S; Hirano K; Hara K; Miyoshi Y; Yukinari T; Itohda Y; Haseba S; Gotoh Y; Nakamura H
Masui; 1983 Mar; 32(3):310-5. PubMed ID: 6864995
[No Abstract] [Full Text] [Related]
16. [The comparison of epidural + methoxy-flurane anesthesia and modified neurolept-anestesia for adrenarectomy in a patient with adrenocortical tumor: with special reference to plasma catecholamine concentration (author's transl)].
Fujii A; Miura M; Iwasaki T; Okada T; Tasiro H; Kawada S
Masui; 1981 Jun; 30(6):588-93. PubMed ID: 7338996
[No Abstract] [Full Text] [Related]
17. [Application of doxapram infusion in modified neuroleptanesthesia].
Okada K; Nagai H; Miyata S; Maruo T; Takeuchi M
Masui; 1974 Aug; 23(8):744-9. PubMed ID: 4473578
[No Abstract] [Full Text] [Related]
18. [Acute intermittent porphyria (author's transl)].
Horn U
Zentralbl Gynakol; 1981; 103(24):1556-9. PubMed ID: 7340306
[No Abstract] [Full Text] [Related]
19. [Acute intermittent porphyria versus porphyria variegata: a diagnostic uncertainty (author's transl)].
Betancor León P; García Ruiz F; Font de Mora Turón A; López Martínez J; Schüller Pérez A
Med Clin (Barc); 1980 Jan; 74(2):61-4. PubMed ID: 7366267
[TBL] [Abstract][Full Text] [Related]
20. [Chloroquine in the treatment of porphyria cutanea tarda symptomatica. Twelve years of experience in 307 patients (author's transl)].
Kordac V; Martásek P; Kaláb M; Semrádová M; Papezová R
Cas Lek Cesk; 1981 Oct; 120(40):1225-7. PubMed ID: 7344792
[No Abstract] [Full Text] [Related]
[Next] [New Search]
